Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Helman

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|September 15, 1990
Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumorsP S Cohen, M J Cooper, L J Helman, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1990
Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblastsM J Cooper, G M Hutchins, P S Cohen, et al.
The Journal of Clinical Investigation|August 1, 1988
Chromogranin A expression in normal and malignant human tissuesL J Helman, A F Gazdar, J G Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Neuropeptide Y expression distinguishes malignant from benign pheochromocytomaL J Helman, P S Cohen, S D Averbuch, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
1 alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell lineM C Velez-Yanguas, T Kalebic, M Maggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Molecular markers of neuroendocrine development and evidence of environmental regulationL J Helman, C J Thiele, W M Linehan, et al.
Oncogene|October 15, 1998
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcomaL Zhang, S Zhan, F Navid, et al.
Cancer Research|March 15, 1996
Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesisL Zhang, F Kashanchi, Q Zhan, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 13, 2012
Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancerH Schayek, I Bentov, J Jacob-Hirsch, et al.
Progress in Clinical and Biological Research|January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumorsM J Cooper, L J Helman, A E Evans, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|September 15, 1990
Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumorsP S Cohen, M J Cooper, L J Helman, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1990
Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblastsM J Cooper, G M Hutchins, P S Cohen, et al.
The Journal of Clinical Investigation|August 1, 1988
Chromogranin A expression in normal and malignant human tissuesL J Helman, A F Gazdar, J G Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Neuropeptide Y expression distinguishes malignant from benign pheochromocytomaL J Helman, P S Cohen, S D Averbuch, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
1 alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell lineM C Velez-Yanguas, T Kalebic, M Maggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Molecular markers of neuroendocrine development and evidence of environmental regulationL J Helman, C J Thiele, W M Linehan, et al.
Oncogene|October 15, 1998
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcomaL Zhang, S Zhan, F Navid, et al.
Cancer Research|March 15, 1996
Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesisL Zhang, F Kashanchi, Q Zhan, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 13, 2012
Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancerH Schayek, I Bentov, J Jacob-Hirsch, et al.
Progress in Clinical and Biological Research|January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumorsM J Cooper, L J Helman, A E Evans, et al.
Pageof 8